Diabetic nephropathy is likely to manifest with comorbidities like hypertension, cardiomyopathy, and other microvascular complications, and these patients would be on multiple drug therapy which is high likely to include an angiotensin-converting enzyme (ACE) inhibitor/AT1 receptor blocker. This evidence concerns the gene AGTR1 and diabetic kidney disease.